CD44 monoclonal antibody for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies

摘要

Compositions comprising antibodies specific for CD44 are provided. These antibodies specifically bind to hematological malignancy cells. Also provided are methods of using CD44 antibodies to target cells that express CD44 for therapeutic and diagnostic purposes. [Selection] FIG. 1A, FIG. 1B, FIG. 1C